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Caries is a global public health problem, whose control requires the introduction of low-cost treatments, such as strong prevention strategies, minimally invasive techniques and 
chemical prevention agents. Nature plays an important role as a source of new antibacterial 
substances that can be used in the prevention of caries, and Brazil is the richest country 
in terms of biodiversity. Objective: In this study, the disk diffusion method (DDM) was 
used to screen over 2,000 Brazilian Amazon plant extracts against Streptococcus mutans. 
Material and Methods: Seventeen active plant extracts were identified and fractionated. 
Extracts and their fractions, obtained by liquid-liquid partition, were tested in the DDM 
assay and in the microdilution broth assay (MBA) to determine their minimal inhibitory 
concentrations (MICs) and minimal bactericidal concentrations (MBCs). The extracts were 
also subjected to antioxidant analysis by thin layer chromatography. Results: EB271, 
obtained from Casearia spruceana, showed significant activity against the bacterium in the 
DDM assay (20.67±0.52 mm), as did EB1129, obtained from Psychotria sp. (Rubiaceae) 
(15.04±2.29 mm). EB1493, obtained from Ipomoea alba, was the only extract to show 
strong activity against Streptococcus mutans (0.08 mg/mL<MIC<0.16 mg/mL; MBC=0.16 
mg/mL) in the MBA. Conclusions: The active extracts, discovered in the Amazon rain forest, 
show potential as sources of new antibacterial agents for use as chemical coadjuvants in 
prevention strategies to treat caries.
Keywords: Streptococcus mutans. Amazonian ecosystem. Plant extracts. Antioxidants. 
Anti-infective agents.
IntroductIon
The introduction of new non-profitable 
therapeutic methods related to the treatment of 
caries disease is a challenge for low- and middle-
income countries that may have effect on children’s 
growth and adults’ general health16. Much has 
already been done with the introduction of new 
approaches, such as minimally invasive techniques5 
and antibiotics20, as well as the popularization 
of and access to toothbrushes, toothpastes18, 
mouth washers and flossing materials. Good diet, 
combined with oral health habits, such as brushing, 
washing, flossing and chewing, may diminish the 
incidence of caries. If caries do occur and dentin is 
involved, chemical-mechanical removal performed 
according to minimally invasive techniques can be 
performed.
Discovering new antibacterial products that 
can be used as coadjuvants in caries treatment 
and in the composition of dentifrices may add 
to the efficacy of oral health programs. Nature 
is one of the main sources of new antimicrobial 
molecules. During the last two decades, natural 
products represented one of the main sources 
of new drugs approved by the Food and Drug 
Administration (FDA)17. Much research has been 
conducted so far, and screening programs have 
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been introduced in many countries, including the 
United States, Madagascar, Cameroon, Indonesia, 
China, India, and many others. In Brazil, screening 
programs have been well established1,19,27,30 since 
the Environment Ministry promulgated MP 2.186 
in August 26th, 2001, introducing guidelines to 
bioprospect the Brazilian biodiversity, which is 
considered to be the richest in the world and one 
of the least studied in terms of its pharmacological 
and chemical potential.
The introduction of new antibacterial compounds 
for use as chemical antibacterial agents in 
dentifrices and cements may play an important 
role in caries prevention and its chemical control, 
particularly compounds obtained from nature. 
Traditionally, natural products are used in dental 
products. For example, eugenol and some plant 
extracts obtained from Zizyphus joazeiro (juá), 
Mentha piperita (mentha) and Punica granatum 
(pomegranate), as well as new natural products, 
are frequently studied8 in the hope of introducing 
them into clinical practices.
Thus, our group carried out a focused search for 
new antimicrobial natural products active against 
Streptococcus involved in oral diseases. Information 
on the microbiological, chemical and antioxidant 
profiles of the active extracts will contribute to the 
identification and development of new antibacterial 
agents for use, in the near future, in prevention 
strategies and as chemical coadjuvant in minimal 
intervention techniques to treat caries.
MaterIal and Methods
Plant collection and extraction preparation
Plants were collected from the Amazon and 
Atlantic rain forests (IBAMA license 12A/2008) 
according to techniques that have been previously 
described26. Briefly, plants were dried in an air-
circulating incubator (Fanem, Diadema, SP, Brazil) 
at 40°C and were ground (Holmes, Danville, Illinois, 
USA). The plant powder was macerated with a 50/50 
solution of dichloromethane and methanol (Synth, 
Diadema, SP, Brazil) for 24 h. After that, solvents 
were evaporated. A second 24 h maceration was 
performed with Milli-Q water (Millipore, Diadema, 
SP, Brazil) before the extract was lyophilized (Virtis, 
Stone Ridge, NY, USA). Organic and aqueous 
extracts were kept at -20°C until use.
extracts and standard drug preparation
Organic extracts were solubilized in 50% 
dimethylsulfoxide (DMSO50; Synth, Diadema, 
SP, Brazil), and aqueous extracts were solubilized 
in Milli-Q water30 (Millipore, Billerica, MA, USA). 
Screening tests in the disk diffusion assay were 
performed with extracts prepared at 200 mg/mL, 
and the selected extracts were prepared at 250, 
200, 150, 100, 50, 25, 12.5, 6.3, 3.2, 1.6, and 
0.8 mg/mL for testing in the microdilution broth 
assay (MBA). Polar and non-polar fractions derived 
from active extracts were prepared in DMSO50 and 
water, respectively, at 200 mg/mL. Chlorhexidine 
digluconate (CHX; Clorexidina S, FGM, Joinville, 
SC, Brazil) was used as standard drug. Final 
concentrations of 0.12, 1 and 2% of CHX were used 
in the assays.
bacteria
Streptococcus mutans (ATCC 25175) was 
obtained from Microbiologics®. Bacteria were kept 
in a mother plaque, in the 3rd passage, and were 
used freshly in the 4th passages in all experiments. 
Bacteria were cultivated in a glass chamber, 
located inside an incubator at 36°C, for 48 h. 
Microaerophyllic conditions were obtained by adding 
a lit candle inside the chamber. After a period of 
time, the oxygen inside the chamber is consumed 
and the fire is extinguished, which permits the 
microaerophyllic environment during the assay. 
Bacteria were resuspended in saline solution at a 
concentration of 0.5 MacFarland (corresponding 
to 1.5x108 CFU/mL) for the disk diffusion method 
(DDM) and at concentrations of 1x107, 1x106, 
1x105, 1x104, 1x103 and 1x102 CFU/mL for the 
microdilution broth assays (MBA)4.
culture medium
Brain heart infusion agar blood (BHIAB; Oxoid, 
Hampshire, UK) was prepared according to the 
manufacturer’s instructions, and defibrinated cattle 
blood was added to the agar medium to a final 
concentration of 5%.
Brain heart infusion broth (BHIB, Oxoid, 
Hampshire, UK) was prepared according to the 
manufacturer’s instructions and was used in the 
MBA in 96-well round bottom microplates (Costar 
Corning, Tewsbury, MA, USA).
disk diffusion method
BHIAB was used as the bacterial growth medium 
for the disk diffusion method (DDM)25 as follows. 
Bacteria were suspended in saline solution at 0.5 
MacFarland and inoculated on BHIAB using a sterile 
swab. Sterile paper disks (Cefar, São Paulo, SP, 
Brazil) measuring 6 mm in diameter and 1 mm in 
height were distributed equally over the inoculated 
blood agar medium. Ten µL of standard drug, 
extracts or fractions were deposited over the paper 
disks. Petri dishes (J.T.Labor; Curitiba, PR, Brazil) 
were kept in microaerophilic-environment chambers 
in incubator at 36°C for 48 hours. The presence of 
a zone of inhibition was considered a positive result 
independent of its diameter. Extracts that inhibited 
bacterial growth in this method were retested 
in triplicate and false positives were eliminated. 
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Means were statistically compared by one-way 
ANOVA (p<0.05) and Tukey post-test (GraphPad® 
Prism 5.0).
Microdilution broth assay
This technique was used to determine the 
minimal inhibitory concentration (MIC) and the 
minimal bactericidal concentration (MBC) using 
different concentrations of active plant extracts 
(final concentrations corresponding to 12.5, 10, 7.5, 
5, 2.5, 1.25, 0.63, 0.31, 0.16, 0.08 and 0.04 mg/
mL) against bacterial suspensions of 1x107, 1x106, 
1x105, 1x104, 1x103 and 1x102 CFU/mL. Briefly, 190 
µL of a bacterial suspension were added to each well 
of 96-well microplates. Next, 10 µl of samples were 
added to the corresponding wells. Each plate was 
set up with a positive and negative bacterial growth 
control. Microplates were kept in a microaerophilic 
environment for 48 h at 36°C.
chromatographic techniques used in the 
fractionation of selected antibacterial 
extracts
Liquid-liquid partition
One gram of each active extract was resuspended 
in 12 mL of a methanol (MeOH, Synth, Diadema, SP, 
Brazil) and water solution (3:1) with the addition 
of chloroform (CHCl3, Synth, Diadema, SP, Brazil) if 
necessary. The extract suspension was transferred 
to a 50 mL burette and washed three times with 25 
mL of CHCl3. All three CHCl3 washes were combined 
and evaporated, producing the chloroform fraction 
(RCHCl3). The aqueous fraction was recuperated 
and allowed to air dry to completely eliminate the 
chloroform. After that, the volume was brought up 
to 10 mL using a 1:1 mixture of methanol and water. 
Forty mL of butanol (BuOH; Synth, Diadema, São 
Paulo, Brazil) were added to the burette, and the 
aqueous fraction was also gently poured into the 
burette. The procedure was repeated with another 
25 mL of BuOH. Both previously obtained BuOH 
volumes were combined and allowed to evaporate, 
yielding the RBuOH fraction. Finally, the aqueous 
fraction RH2O was recuperated and lyophilized.
The three fractions were analyzed by thin 
layer chromatography (Silica Gel GF254, Merck, 
Darmstadt, Germany). Three solvent systems were 
used: hexane:ethyl acetate (4:1), chloroform:ethyl 
acetate (1:1) and chloroform:ethyl acetate:methanol 
(2:2:1). Thin layer plates were first developed with 
ultraviolet light at 254 and 366 nm, followed by 
treatment with 25% sulfuric acid (Synth, Diadema, 
SP, Brazil) and heating29. Then, to determine the 
antioxidant properties, the thin layer plates were 
developed with β-carotene21 (Synth, Diadema, SP, 
Brazil).
results
High-throughput screening using the DDM 
technique was applied to more than 2,000 plant 
extracts against S. mutans and resulted in the 
identification of 17 active aqueous (even numbered 
extracts) and organic (odd numbered extracts) 
plant extracts that somehow inhibited bacterial 
growth in DDM. The botanical names and general 
Collect # Collect date Extract Organ Family Genus Species Author
PSC252 8/8/1997 EB71 Aerial organs Boraginaceae Cordia sp.
AAO3330 9/11/1998 EB271 Leaves Salicaceae Caseria spruceana Benth. Ex Eichler
AAO3330 9/11/1998 EB272 Leaves Salicaceae Caseria spruceana Benth. Ex Eichler
AAO3299 9/10/1998 EB631 Stem Rutaceae Zanthoxylum compactum (Huber ex Albuq.) 
P.G.Waterman
AAO3491 10/1/1999 EB869 Stem Ebenaceae Diospyros guianensis (Aubl.) Gurke
AAO3580 25/02/00 EB1099 Stem Rubiaceae Psychotria sp.
AAO3577 25/02/00 EB1109 Stem Annonaceae Annona hypoglauca Mart.
AAO3543 24/02/00 EB1119 Stem Boraginaceae Cordia cf. exaltata Lam.
AAO3580 25/02/00 EB1129 Aerial organs Rubiaceae Psychotria sp.
IBS142 12/8/2001 EB1343 Leaves Clusiaceae Moronobea coccinea Aubl.
IBS61 11/1/2001 EB1383 Aerial organs Boraginaceae Cordia nodosa Lam.
IBS121 12/7/2001 EB1407 Aerial organs Solanaceae Solanum cf. lanceifolium Jacq.
AAO4031 13/05/02 EB1493 Aerial organs Convolvulaceae Ipomoea alba L.
AAO4067 16/05/02 EB1539 Aerial organs Salicaceae Casearia javitensis H.B.K.
MBP768 27/01/03 EB1673 Stem Annonaceae Annona hypoglauca Mart.
AAO3812 4/5/2002 EB1779 Aerial organs Smilacaceae Smilax sp.
AAO4005 5/11/2002 EB1933 Stem Boraginaceae Cordia sp.
Figure 1- Botanical data related to the plants that originated active extracts
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collection information are displayed in Figure 1.
All 17 extracts were retested in the DDM assay. 
Each extract was analyzed in triplicate, and the 
means and standard deviations (SDs) of diameters 
obtained in two perpendicular measurements of 
each zone of inhibition were obtained in mm (n=6; 
ntotal=120). These results are displayed in Table 1. 
Two percent CHX was used as a standard drug, 
and 50% DMSO and 100% DMSO solvents, which 
were used in the dilution of extracts and fractions, 
were also tested for antibacterial activity. According 
to one-way ANOVA and means comparison 
analysis using Tukey post-test, assuming a 
normal distribution for all media (F(20,125)=170.3; 
r2=0.9701; p<0.05), EB271, obtained from the 
leaves of Casearia spruceana (Salicaceae, Figure 1), 
showed a zone of inhibition diameter (20.67±0.52 
mm) similar to that of 2% CHX (19.28±0.73 mm) 
when tested against S. mutans.
All 17 extracts were fractionated, and the 
fractions were analyzed in the DDM assay. The 
results of the analysis from the RCHCl3 fractions 
are shown in Table 1. It was observed that only the 
RCHCl3 and RBuOH fractions showed antibacterial 
activity. CHX was tested at a 2% dilution and 
in other dilutions commonly used in Dentistry, 
including 0.12% and 1% dilutions, permitting a 
wide range of statistical comparison for practical 
relevance. It was observed that none of the RCHCl3 
fractions showed antibacterial activity compared 
to 2% CHX (p<0.05), which was more effective. 
When compared with 1% CHX, a chlorhexidine 
concentration commonly used in endodontic 
procedures, the RCHCl3 fractions of extracts 
DDM Antibacterial activity Antioxidant activity of fractions
EB# Organic 
extracts
RCHCl3 RBuOH RH2O RDMSO RH2O RBuOH RCHCl3 RDMSO
EB71 10.66±0.59 14.39±0.37** - - □ EB71 - + - □
EB271 20.67±0.52* - 13.83±0.58 - □ EB271 + + - □
EB272 14.65±0.40 - 10.13±0.51 - □ EB272 + + - □
EB631 10.45±0.57 11.24±0.89 - - □ EB631 - + - □
EB869 14.03±0.71 12.04±0.43 - F - EB869 - - - -
EB1099 14.03±1.23 15.34±1.61*** - - - EB1099 - - - -
EB1109 11.04±0.65 15.73±0.83*** 7.97±0.44 - □ EB1109 + - - □
EB1119 11.39±1.18 - - - □ EB1119 - - - □
EB1129 15.04±2.29 17.71±0.91*** - - - EB1129 - - - -
EB1343 9.53±0.52 - - - □ EB1343 + + - □
EB1383 12.17±0.41 12.05±0.61 8.71±0.90 F □ EB1383 + - - □
EB1407 9.51±0.68 - - - □ EB1407 - - - □
EB1493 8.34±1.09 10.78±0.30 - - □ EB1493 - - - □
EB1539 11.56±0.56 - - - - EB1539 + - - +
EB1673 9.99±0.75 10.98±0.47 9.94±0.16 - - EB1673 - + - -
EB1779 14.28±1.45 14.84±0.87*** - - □ EB1779 - - - □
EB1933 8.44±1.42 - - - □ EB1933 - + - □
CHX 0.12% 10.12
CHX 1% 12.37
CHX 2% 19.28±0.73
DMSO 50% 0
DMSO 100% 0
Table 1- Antibacterial activity observed for organic extract and its fractions diluted to 200 mg/mL against Streptococcus 
mutans in the disk diffusion assay in brain heart infusion agar-blood. Means and standard deviation values obtained from 
the growth-inhibition zone diameters are given and are expressed in millimeters (n=6; ntotal=120). One-way ANOVA and 
Tukey's post test were used to compare means (significant if p<0.05). *significance is indicated as a comparison of test 
samples to 1% CHX . Antioxidant activity observed for fractions obtained from active plant extracts
Caption: E#=extract number; FCHCl3=chloroform fraction; FBuOH=buthanol fraction; FMW=methanol: water fraction; 
FDMSO=dimethylsulfoxide; S. mut=Streptococcus mutans; S.sang=Streptococcus sanguinis, CHX=chlorexidin 
digluconate, DMSO=dimethylsulfoxide; RCHCl3=chloroform fraction; RBuOH=buthanol fraction; RH2O=water fraction; 
RDMSO=dimethylsulfoxide fraction; □=does not exist; NT=not tested; (-)=not active; (+)=active
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EB1129, EB1109, EB1099, EB1779 and EB71 were 
the most active (p<0.05); however, the RCHCl3 
fractions from extracts EB869, EB1383, EB631 and 
EB1673 showed activity similar to that observed 
with 1% CHX. The RCHCl3 fractions obtained from 
extracts EB1493 and EB271 did not show significant 
activity (p<0.05). Finally, all RBuOH fractions 
but the one obtained from EB271 showed more 
significant or equal antibacterial activity compared 
to 0.12% CHX, a concentration commonly used in 
mouth rinses. Table 1 also shows results obtained 
from the analysis of the RBuOH fractions obtained 
from the active extracts. One-way ANOVA and 
Tukey post-test indicated that only the RBuOH 
fraction obtained from EB271 showed significant 
antibacterial activity (p<0.05) compared with 
0.12% CHX and 1% CHX. None of the fractions 
showed better activity than 2% CHX. The RBuOH 
fractions obtained from EB272 and EB1673 
showea antibacterial activity similar to 0.12% CHX 
(p>0.05). None of the other fractions had significant 
activity compared with the three dilutions of CHX.
Microdilution broth assay was performed on all 
seventeen extracts to determine the MICs and MBCs 
against S. mutans in bacterial suspensions prepared 
at 1x102, 1x103, 1x104, 1x105, 1x106 and 1x107 
CFU/mL. Extracts were ranked (Table 2) according 
to their efficacy in bacterial growth inhibition and 
were considered efficient if their MBC≤0.31 mg/
mL. Based on this parameter, EB1493 was the only 
extract that hsa significant MIC and MBC (0.08 mg/
mL<MIC<0.16 mg/mL and MBC=0.16 mg/mL) 
using a S. mutans suspension at 1x107 CFU/mL. 
EB1493 was obtained from aerial organs of Ipomoea 
alba L. (Convolvulaceae, Figure 1). According to the 
Clinical Laboratory Standards Institute parameters 
(2003), MIC values are supposed to be obtained 
at bacterial concentration of 1x105 CFU/mL. When 
the results are analyzed with this approach, shown 
in Table 2, EB1493 showed the best activity (0.04 
mg/mL<MIC<0.016 mg/mL and MBC=0.16 mg/
mL), followed by EB1099 and EB1779 (0.31 mg/
mL<MIC<0.63 mg/mL and MBC’s=0.63 mg/mL) 
and EB869 (0.31 mg/mL<MIC<0.63 mg/mL and 
MBC=2.5 mg/mL).
The antioxidant activity of all extracts and their 
fractions was also determined (Table 1). Antioxidant 
activity was found in the RBuOH fraction from 
extracts EB71, EB631, EB1673 and EB1933, in the 
RH2O fraction from extracts EB1109 and EB1383, in 
both the RBuOH and RH2O fractions from extracts 
EB271, EB272 and EB1343, and in the RH2O and 
RDMSO fractions from extract EB1539. Only nine of 
the original 17 extract fractions showed antioxidant 
activity, and these were concentrated mainly in 
the RBuOH and RH2O fractions. None of the FMW 
fractions showed antibacterial activity, and only six 
RBuOH fractions, originating from extracts EB271, 
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EB272, EB631, EB1343, EB1673 and EB1933, 
showed both antibacterial and antioxidant activities. 
Finally, the RBuOH fractions obtained from extracts 
EB271, EB272 and EB1673 were active against S. 
mutans in the DDM assay and showed antioxidant 
activity.
dIscussIon
Brazil is the richest country in the world in terms 
of biodiversity, and its forests can be considered 
a potential source of new products for use as 
antimicrobial agents in Dentistry. A high-throughput 
screening-like (HTS) approach was chosen to 
determine the antibacterial activity of over 2,000 
plant extracts against Streptococcus mutans30. 
Seventeen out of 2,000 plant extracts were active 
against the bacteria (0.85% yield).
The extracts that were the most active in the 
DDM assay were EB271, obtained from the leaves 
of C. spruceana, and EB1129, obtained from the 
aerial organs of Psychotria sp. (Rubiaceae). After 
fractionation, the RBuOH fraction obtained from 
EB271 showed antibacterial activity in the DDM 
assay and showed the presence of antioxidant 
compounds. No pharmacological studies have been 
conducted on C. spruceana, but species belonging 
to the genus Casearia are well documented as 
C. sylvestris. The Clerodane diterpenoids named 
casearins A-F were isolated from C. sylvestris12, 
and, since then, many authors have demonstrated 
different pharmacological or biological properties 
related to this group of compounds, including 
antitumor activity12, antiulcer activity2, anti-snake22 
and anti-bee3 venoms, antiplasmodial activity24, 
anti-inflammatory activity6 and anti-hyperlipidemic 
activity23. The antibacterial activity observed 
in the RBuOH fraction of EB271 may indicate a 
possible effect related to intermediate-polar or 
polar substances, substantiating the antibacterial 
activity observed in the EB272 extract, which is an 
aqueous extract obtained from the same leaves 
used to obtain the organic extract EB271.
EB1129 also showed interesting activity in the 
DDM assay, and its RCHCl3 fraction showed the best 
activity against S. mutans of all the tested fractions. 
No antioxidant activity was observed for EB1129 
or its fractions. One of the main chemical groups 
expected to be found in Psychotria are alkaloids 
from the indole7 and cyclotide9 groups. Psychoactive 
dimethyltryptamin was isolated from the ayahuasca 
Amazon plant Psychotria viridis28. Psychollatine, 
a monoterpene indole alkaloid, was isolated 
from P. umbellata and was verified to present an 
opioid-like analgesic effect, as well as antioxidant, 
antimutagenic, anxiolytic, antidepressant and 
antipsychotic activities in rodents.
Extracts that showed the best results in the 
DDM assay differed from those with the best 
results in MBA. All of the extracts were tested 
at concentrations of 200 mg/mL in the DDM 
assay, whereas the same extracts were tested at 
concentrations 16 to 5,000 times more dilute in 
MBA. Presumably, the difference in concentration 
is one of the reasons for the different results, but it 
may also be related to the sensitivity of each assay 
or to the chemical composition of the extracts, as 
discussed elsewhere.
Only the extract EB1493, obtained from the 
aerial organs of Ipomoea alba L. (Convolvulaceae), 
showed antibacterial activity in MBA. I. alba has 
not been well studied in terms of its chemical 
constituents or pharmacological activity. The use 
of its latex was revealed in 199911. Sweet potato 
is one of the species belonging to the Ipomoea 
genus. Clavine alkaloids occur in I. muricata15, as 
do ipobscurines that are macrolactam-type indole 
alkaloids13, and alkaloids occur in some toxic 
species, as in I. carnea10. Other compounds, such 
as anthocyanins25 and polyphenolic compounds14, 
also occur in Ipomoea species.
Seventeen out of over 2,000 Brazilian Amazon 
plant extracts have been identified as potential 
anti-Streptococcal agents. Extracts and their 
fractions showed significant antibacterial activity 
against microorganisms involved in caries, which 
is one of the most important infectious diseases 
around the world, particularly in developing 
countries. These extracts represent the most 
important breakthrough in the development of new 
pharmacological weapons for Dentistry based on 
the biodiversity found in the Amazon rain forest.
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